Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2016 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
FLGT on Nasdaq
Shares outstanding
30,210,911
Price per share
$26.27
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
17,228,107
Total reported value
$389,318,961
% of total 13F portfolios
0%
Share change
+914,837
Value change
+$21,532,520
Number of holders
162
Price from insider filings
$26.27
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BARCLAYS PLC 7.6% +43% $40,525,356 +$11,791,193 2,338,451 +41% Barclays PLC 31 Mar 2025
BlackRock, Inc. 5.9% $31,537,533 1,819,823 BlackRock, Inc. 31 Mar 2025
MILLENNIUM MANAGEMENT LLC 5.6% +18% $34,326,845 +$5,063,349 1,691,811 +17% Millennium Management LLC 22 Jul 2025

As of 30 Sep 2025, 162 institutional investors reported holding 17,228,107 shares of Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT). This represents 57% of the company’s total 30,210,911 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) together control 47% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 9.8% 2,975,411 +38% 0% $67,244,288
MILLENNIUM MANAGEMENT LLC 4.9% 1,468,844 +1.8% 0.03% $33,195,874
VANGUARD GROUP INC 3.9% 1,179,254 +1.1% 0% $26,651,141
ACADIAN ASSET MANAGEMENT LLC 3.8% 1,140,163 +2% 0.04% $25,754,000
DIMENSIONAL FUND ADVISORS LP 3.8% 1,133,103 -0.12% 0.01% $25,607,425
D. E. Shaw & Co., Inc. 1.9% 567,770 +19% 0.01% $12,831,602
DEUTSCHE BANK AG\ 1.7% 504,485 +52% 0% $11,401,361
STATE STREET CORP 1.7% 501,996 -2.3% 0% $11,345,110
GEODE CAPITAL MANAGEMENT, LLC 1.7% 501,671 -2.3% 0% $11,339,902
AMERIPRISE FINANCIAL INC 1.6% 494,953 -0.69% 0% $11,185,938
CITADEL ADVISORS LLC 1.2% 371,476 -38% 0.01% $8,395,357
Point72 Asset Management, L.P. 1.2% 371,261 -32% 0.02% $8,390,505
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.2% 359,281 +20% 0% $8,119,751
Connor, Clark & Lunn Investment Management Ltd. 1.1% 331,526 +8.6% 0.02% $7,492,488
JPMORGAN CHASE & CO 0.99% 299,014 +767% 0% $6,757,717
Nuveen, LLC 0.96% 290,853 -5.8% 0% $6,573,278
MORGAN STANLEY 0.92% 276,558 +23% 0% $6,250,214
Diametric Capital, LP 0.8% 241,622 +43% 2% $5,460,657
NORTHERN TRUST CORP 0.66% 200,826 +0.2% 0% $4,538,668
GOLDMAN SACHS GROUP INC 0.61% 183,998 +58% 0% $4,158,355
BARCLAYS PLC 0.59% 178,867 -9.5% 0% $4,042,394
Trexquant Investment LP 0.57% 172,372 +42% 0.04% $3,895,607
TUDOR INVESTMENT CORP ET AL 0.57% 171,495 -7.3% 0.03% $3,875,787
Peapod Lane Capital LLC 0.54% 164,579 +1.1% 3.3% $3,719,789
TWO SIGMA INVESTMENTS, LP 0.52% 157,608 +68% 0.01% $3,561,941

Institutional Holders of Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 115,533 $3,035,207 +$2,000,385 $26.27 15
2025 Q3 17,228,107 $389,318,961 +$21,532,520 $22.60 162
2025 Q2 16,260,263 $323,227,753 +$1,152,433 $19.88 165
2025 Q1 16,317,307 $275,768,282 -$14,217,124 $16.90 173
2024 Q4 17,013,356 $314,235,330 +$12,922,113 $18.47 185
2024 Q3 16,092,056 $349,643,308 +$18,518,549 $21.73 182
2024 Q2 15,273,537 $299,689,127 +$11,542,022 $19.62 170
2024 Q1 14,618,717 $317,198,022 +$3,830,687 $21.70 177
2023 Q4 8,392 $242,613 -$6,881 $28.91 1
2023 Q3 14,020,483 $374,897,598 +$4,161,478 $26.74 192
2023 Q2 13,768,316 $509,751,733 +$9,352,138 $37.03 205
2023 Q1 13,193,265 $411,886,817 +$14,172,907 $31.22 207
2022 Q4 13,102,485 $390,249,510 -$9,203,141 $29.78 212
2022 Q3 12,908,499 $491,999,417 -$6,654,743 $38.12 205
2022 Q2 12,964,270 $706,485,450 +$53,376,155 $54.53 244
2022 Q1 12,035,482 $750,863,864 +$36,802,012 $62.41 259
2021 Q4 11,137,245 $1,120,389,576 -$25,536,273 $100.59 279
2021 Q3 11,357,988 $1,021,404,763 +$60,047,982 $89.95 255
2021 Q2 10,630,094 $980,329,923 +$54,160,538 $92.23 242
2021 Q1 10,005,673 $965,789,460 +$73,846,775 $96.62 242
2020 Q4 9,443,194 $491,967,681 +$75,927,849 $52.10 178
2020 Q3 8,022,121 $321,185,445 +$78,964,167 $40.04 116
2020 Q2 5,710,355 $91,361,792 +$12,698,343 $16.00 76
2020 Q1 6,007,543 $64,430,760 +$4,043,997 $10.76 68
2019 Q4 5,662,771 $73,031,000 +$35,446,857 $12.90 67
2019 Q3 2,926,834 $30,405,010 +$16,885,754 $10.39 31
2019 Q2 1,301,144 $8,691,007 +$409,589 $6.68 12
2019 Q1 1,242,251 $7,392,006 +$220,571 $5.95 14
2018 Q4 1,210,059 $3,835,003 -$981,189 $3.17 13
2018 Q3 1,458,250 $5,731,004 +$22,467 $3.93 15
2018 Q2 1,452,436 $6,013,004 +$11,603 $4.14 15
2018 Q1 1,449,767 $5,789,004 +$112,497 $3.99 18
2017 Q4 1,415,028 $6,198,004 -$6,545,613 $4.38 15
2017 Q3 2,389,480 $11,374,005 -$4,070,148 $4.78 18
2017 Q2 2,976,441 $19,019,006 -$5,817,347 $6.39 20
2017 Q1 3,491,914 $38,132,153 +$4,848,435 $10.92 34
2016 Q4 3,066,506 $35,477,491 +$8,314,923 $11.57 36
2016 Q3 2,647,726 $21,831,584 +$21,831,584 $9.22 16